These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19473343)

  • 1. Development of cardiac dysfunction induced by repetitive transient myocardial ischemia is inhibited by edaravone in conscious rats.
    Toyota E; Miyamoto Y; Imai K; Neishi Y; Kawamoto T; Okura H; Yoshida K
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):e20-5. PubMed ID: 19473343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antioxidant edaravone attenuates pressure overload-induced left ventricular hypertrophy.
    Tsujimoto I; Hikoso S; Yamaguchi O; Kashiwase K; Nakai A; Takeda T; Watanabe T; Taniike M; Matsumura Y; Nishida K; Hori M; Kogo M; Otsu K
    Hypertension; 2005 May; 45(5):921-6. PubMed ID: 15824197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
    Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor.
    Zhang WW; Bai F; Wang J; Zheng RH; Yang LW; James EA; Zhao ZQ
    Drug Des Devel Ther; 2017; 11():3019-3033. PubMed ID: 29081650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis.
    Xi H; Akishita M; Nagai K; Yu W; Hasegawa H; Eto M; Kozaki K; Toba K
    Atherosclerosis; 2007 Apr; 191(2):281-9. PubMed ID: 16806227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis.
    Shimazaki H; Watanabe K; Veeraveedu PT; Harima M; Thandavarayan RA; Arozal W; Tachikawa H; Kodama M; Aizawa Y
    Free Radic Res; 2010 Sep; 44(9):1082-90. PubMed ID: 20815771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney.
    Doi K; Suzuki Y; Nakao A; Fujita T; Noiri E
    Kidney Int; 2004 May; 65(5):1714-23. PubMed ID: 15086910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of edaravone, a free radical scavenger, on left ventricular function and structure in diabetes mellitus.
    Hayashi T; Mori T; Sohmiya K; Okada Y; Inamoto S; Okuda N; Mori H; Kitaura Y
    J Cardiovasc Pharmacol; 2003 Jun; 41(6):923-9. PubMed ID: 12775971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
    Inokuchi Y; Imai S; Nakajima Y; Shimazawa M; Aihara M; Araie M; Hara H
    J Pharmacol Exp Ther; 2009 May; 329(2):687-98. PubMed ID: 19201991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of edaravone on the production of tumor necrosis factor-alpha in the isolated heart undergoing ischemia and reperfusion.
    Onimaru S; Nakamura K; Kariyazono H; Ikeda R; Ueno T; Fukumoto Y; Yabuki A; Sakata R; Yamada K
    Heart Vessels; 2006 Mar; 21(2):108-15. PubMed ID: 16550312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of edaravone against hypoxia-reoxygenation injury in rabbit cardiomyocytes.
    Yamawaki M; Sasaki N; Shimoyama M; Miake J; Ogino K; Igawa O; Tajima F; Shigemasa C; Hisatome I
    Br J Pharmacol; 2004 Jun; 142(3):618-26. PubMed ID: 15148265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship of 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone).
    Watanabe K; Morinaka Y; Iseki K; Watanabe T; Yuki S; Nishi H
    Redox Rep; 2003; 8(3):151-5. PubMed ID: 12935312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edaravone, a newly developed radical scavenger, protects against ischemia-reperfusion injury of the small intestine in rats.
    Tomatsuri N; Yoshida N; Takagi T; Katada K; Isozaki Y; Imamoto E; Uchiyama K; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
    Int J Mol Med; 2004 Jan; 13(1):105-9. PubMed ID: 14654979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Edaravone Improves Septic Cardiac Function by Inducing an HIF-1
    He C; Zhang W; Li S; Ruan W; Xu J; Xiao F
    Oxid Med Cell Longev; 2018; 2018():5216383. PubMed ID: 29765498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edaravone prevented deteriorated cardiac function after myocardial ischemia-reperfusion via inhibiting lipid peroxidation in rat.
    Yagi H; Horinaka S; Matsuoka H
    J Cardiovasc Pharmacol; 2005 Jul; 46(1):46-51. PubMed ID: 15965354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin inhibits cardiac hypertrophy and improves cardiovascular function via enhanced Na
    Bai XJ; Hao JT; Wang J; Zhang WF; Yan CP; Zhao JH; Zhao ZQ
    Pharmacol Rep; 2018 Feb; 70(1):60-68. PubMed ID: 29331788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a novel free radical scavenger, for treatment of cardiovascular diseases.
    Higashi Y; Jitsuiki D; Chayama K; Yoshizumi M
    Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):85-93. PubMed ID: 18221078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats.
    Zhou S; Yu G; Chi L; Zhu J; Zhang W; Zhang Y; Zhang L
    Neurotoxicology; 2013 Sep; 38():136-45. PubMed ID: 23932983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain.
    Zhang W; Sato K; Hayashi T; Omori N; Nagano I; Kato S; Horiuchi S; Abe K
    Neurol Res; 2004 Apr; 26(3):342-8. PubMed ID: 15142331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.